![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsors and Collaborators: |
The Cooper Institute Cargill |
---|---|
Information provided by: | The Cooper Institute |
ClinicalTrials.gov Identifier: | NCT00153738 |
This study examined the effects of 2.6 g/d of phytosterol ingestion on LDL cholesterol metabolism. It is expected that this dose will significantly reduce LDL cholesterol after 12 weeks of supplementation.
Condition | Intervention |
---|---|
Hypercholesteremia |
Drug: phytosterol |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Single Blind, Placebo Control, Single Group Assignment, Efficacy Study |
Official Title: | Effectiveness of Phytosterol Supplementation on Select Indices of Cardiovascular Risk |
Estimated Enrollment: | 72 |
Study Start Date: | March 2004 |
Estimated Study Completion Date: | August 2005 |
This study examined the effects of 2.6 g/d of phytosterol ingestion on LDL cholesterol metabolism. It is expected that this dose will significantly reduce LDL cholesterol after 12 weeks of supplementation.
The study recruited 72 men and women 20-70 years of age with mild hypercholesteremia (>130 mg/dl LDL-C). They were assigned to 1 of 2 groups. Participants ingested the supplement or a placebo for 12 weeks, with an interim assessment at 6 weeks. Participants agreed to maintain current diet, medication, and exercise habits and to not donate blood during the trial.
Ages Eligible for Study: | 20 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | CI0129 |
Study First Received: | September 7, 2005 |
Last Updated: | September 7, 2005 |
ClinicalTrials.gov Identifier: | NCT00153738 |
Health Authority: | United States: Institutional Review Board |
LDL-C, phytosterol |
Metabolic Diseases Hyperlipidemias Metabolic disorder |
Hypercholesterolemia Dyslipidemias Lipid Metabolism Disorders |